Source:http://linkedlifedata.com/resource/pubmed/id/16602121
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-5-25
|
pubmed:abstractText |
Acute and chronic osteomyelitis caused by staphylococci can be difficult to treat by conventional means and often has marked consequences for the patient. Current methods of treatment involve the use of systemic antibiotics, the local implantation of nondegradable drug carriers, and surgical debridement. A possible solution that could prevent initial bacterial adhesion could be to modify the implant surface with an antimicrobial coating while maintaining biocompatibility to host cells. This study describes the cytocompatibility evaluation of different coatings (poly(D,L-lactide) (PDLLA), politerefate (PTF), calcium phosphate/anodic plasma-chemical treatment (CaP/APC), polyurethane (PU), and polyvinylpyrollidone (PVP) on titanium surfaces with and without chlorhexidine diacetate (CHA) to Staphylococcus aureus, Staphylococcus epidermidis, and hTERT human fibroblasts. Surface characterization of the coatings showed no significant variation in the roughness or hydrophobicity of the coated surfaces, except the CaP/APC surface that was porous yet the smoothest, and PVP, PVP+CHA, and CaP/APC+CHA that were more hydrophilic in nature than the others. On the surfaces without CHA, both staphylococcal strains and spread fibroblasts were observed, but on the CHA impregnated surfaces few bacteria and no intact fibroblasts were seen. Flow cytometry found fewer bacteria in the media and on the surfaces containing CHA in comparison to the surfaces without CHA. The release kinetics varied from slow (over 200 h) to burst release: PDLLA>PTF>PU>CaP/APC=PVP. This study showed that PDLLA and PTF have the best potential as coatings on implants for drug delivery, as they were cytocompatible to hTERT fibroblasts, eluted CHA effectively, and passed mechanical testing. The actual release kinetics of PDLLA and PTF are important, as the amount of CHA present should remain above the minimal inhibitory concentration value for a limited time before disappearing completely.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1549-3296
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2006 Wiley Periodicals, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
50-8
|
pubmed:meshHeading |
pubmed-meshheading:16602121-Cell Line, Transformed,
pubmed-meshheading:16602121-Coated Materials, Biocompatible,
pubmed-meshheading:16602121-Fibroblasts,
pubmed-meshheading:16602121-Humans,
pubmed-meshheading:16602121-Materials Testing,
pubmed-meshheading:16602121-Microscopy, Electron, Scanning,
pubmed-meshheading:16602121-Staphylococcus aureus,
pubmed-meshheading:16602121-Staphylococcus epidermidis,
pubmed-meshheading:16602121-Titanium
|
pubmed:year |
2006
|
pubmed:articleTitle |
Bacteria and cell cytocompatibility studies on coated medical grade titanium surfaces.
|
pubmed:affiliation |
AO Research Institute, Clavadelerstrasse, 7270 Davos, Switzerland. llinos.harris@yahoo.co.uk
|
pubmed:publicationType |
Journal Article
|